Product puzzle: food makers weigh up rise of GLP-1 drugs

What does the growing use of GLP-1 medications mean for food manufacturers? Is it a trend on which they can capitalise or will its growing use be detrimental to their business? And, if it does present an opportunity, which product categories offer the greatest scope for them to cash in? 

While the early evidence suggests consumers on GLP-1 drugs are eating less and spending less – particularly on fast foods and snacks – as it is still early days, the spending patterns of users hasn’t settled down enough for many food manufacturers to start developing products that specifically target the users of the medication. More…